Cargando…
Potential health risks of mRNA-based vaccine therapy: A hypothesis
Therapeutic applications of synthetic mRNA were proposed more than 30 years ago, and are currently the basis of one of the vaccine platforms used at a massive scale as part of the public health strategy to get COVID-19 under control. To date, there are no published studies on the biodistribution, ce...
Autores principales: | Acevedo-Whitehouse, K., Bruno, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876036/ https://www.ncbi.nlm.nih.gov/pubmed/36718314 http://dx.doi.org/10.1016/j.mehy.2023.111015 |
Ejemplares similares
-
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
por: Trougakos, Ioannis P., et al.
Publicado: (2022) -
Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA
por: Milano, Gerard, et al.
Publicado: (2021) -
mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021) -
mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023) -
Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy
por: Tang, Xiangjun, et al.
Publicado: (2022)